What is RefleXion?
RefleXion is a life sciences innovator founded in 2010 and based in Hayward, California, dedicated to transforming cancer treatment through its unique biotargeting oncology platform. The company's technology aims to provide a more precise and effective approach to radiation therapy, offering new hope for patients battling various forms of cancer. By focusing on targeted treatment delivery, RefleXion seeks to minimize damage to healthy tissues while maximizing therapeutic impact on malignant cells, positioning itself at the forefront of oncological advancements.
How much funding has RefleXion raised?
RefleXion has raised a total of $587.6M across 8 funding rounds:
Series A
$11.6M
Series B
$6M
Series C
$100M
Unspecified
$60M
Private Equity
$100M
Private Equity
$80M
Debt
$125M
Other Financing Round
$105M
Series A (2014): $11.6M with participation from Sofinnova Partners and Venrock
Series B (2016): $6M led by Pfizer Venture Investments, Sofinnova Partners, Venrock, and KCK
Series C (2018): $100M supported by GT Healthcare Capital Partners, KCK, Pfizer Venture Investments, Sofinnova Partners, The Rise Fund, and Venrock
Unspecified (2019): $60M featuring Oxford Finance
Private Equity (2020): $100M backed by Public Sector Pension Investment Board
Private Equity (2022): $80M with participation from KCK Group, T. Rowe Price, PSP Investments, and The Rise Fund
Debt (2022): $125M led by Oxford Finance
Other Financing Round (2023): $105M supported by Pictet Asset Management, TPG, Johnson & Johnson, Squarepoint Capital, T. Rowe Price, Pfizer, Ally Bridge Group, and The Rise Fund
Key Investors in RefleXion
Ally Bridge Group
Ally Bridge Group is a global healthcare investment management firm specializing in life science innovation, with a focus on both private and public equity strategies. They aim to generate superior returns while addressing unmet medical needs through scientific research and financial expertise.
The Rise Fund
The Rise Fund is an impact investing platform focused on growth-stage, mission-driven companies aligned with UN Sustainable Development Goals, investing across sectors including healthcare to achieve positive social and environmental outcomes.
Pfizer
Pfizer is a biopharmaceutical company that researches, develops, manufactures, and markets medicines and vaccines across multiple therapeutic areas, including oncology, to help prevent, treat, and manage disease worldwide.
What's next for RefleXion?
The recent influx of major strategic investment signals a new phase of growth and development for RefleXion. This capital infusion is expected to accelerate the company's research and development initiatives, potentially expanding its clinical trials, enhancing its technology platform, and broadening its market reach. With a history of substantial backing from prominent investors in the healthcare and life sciences sectors, RefleXion is well-positioned to further its mission of revolutionizing cancer care and improving patient outcomes globally. The company's trajectory suggests a strong focus on scaling its operations and solidifying its position as a leader in advanced radiation therapy.
See full RefleXion company page
